Evidence map›Paper›PMID 25634938›Full record

ArticleNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2016

Tobacco Control and Health Advocacy in the European Union: Understanding Effective Coalition-Building.

Heide Weishaar, Jeff Collin, Amanda Amos

Open access · hybridAbstract read
In one paragraph

Article in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
10.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Tobacco Control in Denmark: How the Ugly Duckling Turned into a Swan.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Article
  4. Isolation of starch and protein degrading strainFrontiers in microbiology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Historic tobacco legislation in Israel: a moment to celebrate.Israel journal of health policy research · 2020
    Article
  10. Article
  11. Article
  12. Insights in Public Health: Formative Factors for a Statewide Tobacco Control Advocacy Infrastructure: Insights from Hawai'i.Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health · 2019
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Heide WeishaarMRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK; heide.weishaar@glasgow.ac.uk.
Jeff CollinGlobal Public Health Unit, School of Social and Political Science, University of Edinburgh, Edinburgh, UK;
Amanda AmosCentre for Population Health Sciences, University of Edinburgh, Edinburgh, UK.
Public Health Scotland · GBUniversity of Edinburgh · GBUniversity of Glasgow · GB

Funding

Tobacco Companies, Global Governance and Public HealthR01CA160695 · NCI · UNIVERSITY OF BATH · PI GILMORE, ANNA B · 2011 to 2013
$1.3M
British Heart FoundationCancer Research UKDepartment of HealthMedical Research Council MC_U130085862Medical Research Council MC_UU_12017/6Medical Research Council MR/K023195/1NCI NIH HHS R01 CA160695NCI NIH HHS R01 CA160695-01
6 · The paper itself

Abstract

introductionCoalitions of supporters of comprehensive tobacco control policy have been crucial in achieving policy success nationally and internationally, but the dynamics of such alliances are not well understood.

methodsQualitative semi-structured, narrative interviews with 35 stakeholders involved in developing the European Council Recommendation on smoke-free environments. These were thematically analyzed to examine the dynamics of coalition-building, collaboration and leadership in the alliance of organizations which successfully called for the development of comprehensive European Union (EU) smoke-free policy.

resultsAn alliance of tobacco control and public health advocacy organizations, scientific institutions, professional bodies, pharmaceutical companies, and other actors shared the goal of fighting the harms caused by second-hand smoke. Alliance members jointly called for comprehensive EU smoke-free policy and the protection of the political debates from tobacco industry interference. The alliance's success was enabled by a core group of national and European actors with long-standing experience in tobacco control, who facilitated consensus-building, mobilized allies and synchronized the actions of policy supporters. Representatives of Brussels-based organizations emerged as crucial strategic leaders.

conclusionsThe insights gained and identification of key enablers of successful tobacco control advocacy highlight the strategic importance of investing into tobacco control at European level. Those interested in effective health policy can apply lessons learned from EU smoke-free policy to build effective alliances in tobacco control and other areas of public health.

Indexed as

European UnionSmoking PreventionConsumer AdvocacyHealth Care CoalitionsHealth PolicyHumansPublic HealthSmoke-Free PolicySmokingTobacco IndustryTobacco Smoke PollutionTobacco Smoke Pollution

Identifiers

PMID25634938
PMCPMC4710205
OpenAlexW1973323570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.